万东医疗
(600055)
| 流通市值：111.58亿 | | | 总市值：111.58亿 |
| 流通股本：7.03亿 | | | 总股本：7.03亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,188,509,072.63 | 843,329,490.05 | 373,277,998.39 | 1,524,354,161.43 |
| 营业收入 | 1,188,509,072.63 | 843,329,490.05 | 373,277,998.39 | 1,524,354,161.43 |
| 二、营业总成本 | 1,236,567,549.4 | 808,339,870.48 | 358,486,933.72 | 1,361,474,392.59 |
| 营业成本 | 800,794,501.54 | 546,847,151.6 | 232,380,317.2 | 967,141,752.31 |
| 税金及附加 | 7,842,866.5 | 5,974,248.02 | 1,889,477.99 | 14,848,692.83 |
| 销售费用 | 197,899,218.04 | 116,884,599.74 | 60,600,749.81 | 219,402,271.74 |
| 管理费用 | 79,816,094.79 | 53,832,496.4 | 21,820,465.86 | 69,597,988.82 |
| 研发费用 | 182,109,966.93 | 107,291,150.36 | 55,667,880.17 | 165,233,686.54 |
| 财务费用 | -31,895,098.4 | -22,489,775.64 | -13,871,957.31 | -74,749,999.65 |
| 其中:利息费用 | 558,734.77 | 385,704.96 | - | 1,646,918.75 |
| 其中:利息收入 | 37,861,327.81 | 25,501,251.22 | 14,908,321.4 | 72,234,687.01 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 375,753.42 | 928,054.79 | 1,430,410.96 | -2,998,534.83 |
| 加:投资收益 | 3,790,558.47 | 1,400,483.41 | -48,753.38 | 6,518,343.78 |
| 资产处置收益 | -70,123.79 | -69,616.51 | -61,420.23 | 120,751.58 |
| 资产减值损失(新) | - | - | - | -4,037,692.52 |
| 信用减值损失(新) | -13,053,214.07 | -6,227,045.46 | 1,417.32 | -25,427,314.05 |
| 其他收益 | 35,817,348.55 | 27,021,637.35 | 22,773,645.65 | 26,285,260.72 |
| 四、营业利润 | -21,198,154.19 | 58,043,133.15 | 38,886,364.99 | 163,340,583.52 |
| 加:营业外收入 | - | - | - | 6,343,723.96 |
| 减:营业外支出 | - | - | - | 2,824,674.76 |
| 五、利润总额 | -21,198,154.19 | 58,043,133.15 | 38,886,364.99 | 166,859,632.72 |
| 减:所得税费用 | 6,348,317.64 | 6,338,483.71 | 3,988,709.84 | 8,217,347.42 |
| 六、净利润 | -27,546,471.83 | 51,704,649.44 | 34,897,655.15 | 158,642,285.3 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -27,546,471.83 | 51,704,649.44 | 34,897,655.15 | 158,642,285.3 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -27,209,818.77 | 51,298,644.68 | 35,052,178.64 | 157,350,997.13 |
| 少数股东损益 | -336,653.06 | 406,004.76 | -154,523.49 | 1,291,288.17 |
| 扣除非经常损益后的净利润 | -44,575,434.71 | 35,633,618.97 | 23,268,905.22 | 142,416,193.02 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.04 | 0.07 | 0.05 | 0.22 |
| (二)稀释每股收益 | -0.04 | 0.07 | 0.05 | 0.22 |
| 八、其他综合收益 | - | - | - | -1,943,100 |
| 归属于母公司股东的其他综合收益 | - | - | - | -1,943,100 |
| 九、综合收益总额 | -27,546,471.83 | 51,704,649.44 | 34,897,655.15 | 156,699,185.3 |
| 归属于母公司股东的综合收益总额 | -27,209,818.77 | 51,298,644.68 | 35,052,178.64 | 155,407,897.13 |
| 归属于少数股东的综合收益总额 | -336,653.06 | 406,004.76 | -154,523.49 | 1,291,288.17 |
| 公告日期 | 2025-10-25 | 2025-08-23 | 2025-04-26 | 2025-03-22 |
| 审计意见(境内) | | | | 标准无保留意见 |